TrialBritish journal of clinical pharmacology2018

Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first-in-human trial in healthy postmenopausal women.

Oliver Pohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.